GlassScriptPhysician profile
William T Bohannon
NPI 1023077864
$3,639.70
in general payments reported to CMS, 2019-2025
10 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $352 · 2021: $582 · 2022: $482 · 2023: $872 · 2024: $170 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,710.94 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Medtronic, INC. | $746.20 | 2021-2025 | Endurant Iis |
| Medtronic Vascular, INC. | $386.38 | 2019-2020 | |
| Cook Medical LLC | $290.80 | 2023-2024 | Zenith, Zenith Spiral-Z |
| Shockwave Medical, INC | $149.05 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $144.30 | 2020 | |
| Silk Road Medical, INC. | $142.91 | 2021 | |
| Neuros Medical, INC. | $51.14 | 2025 | Altius |
| Getinge USA Sales, LLC | $17.98 | 2023 | Flixene |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bohannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.